Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region
- 19 January 2007
- journal article
- Published by BMJ in Journal of Medical Genetics
- Vol. 44 (7), 448-451
- https://doi.org/10.1136/jmg.2006.047373
Abstract
A 4.3 Mb duplication of chromosome 21 bands q22.13–q22.2 was diagnosed by interphase fluorescent in-situ hybridisation (FISH) in a 31-week gestational age baby with cystic hygroma and hydrops; the duplication was later found in the mother and in her 8-year-old daughter by the same method and confirmed by array comparative genomic hybridisation (aCGH). All had the facial gestalt of Down syndrome (DS). This is the smallest accurately defined duplication of chromosome 21 reported with a DS phenotype. The duplication encompasses the gene DYRK1 but not DSCR1 or DSCAM, all of which have previously been implicated in the causation of DS. Previous karyotype analysis and telomere screening of the mother, and karyotype analysis and metaphase FISH of a chorionic villus sample, had all failed to reveal the duplication. The findings in this family add to the identification and delineation of a “critical region” for the DS phenotype on chromosome 21. Cryptic chromosomal abnormalities can be missed on a routine karyotype for investigation of abnormal prenatal ultrasound findings, lending support to the use of aCGH analysis in this setting.Keywords
This publication has 30 references indexed in Scilit:
- NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21Nature, 2006
- Fine-scale structural variation of the human genomeNature Genetics, 2005
- Detection of large-scale variation in the human genomeNature Genetics, 2004
- Large-Scale Copy Number Polymorphism in the Human GenomeScience, 2004
- Pregnancy outcome of 30 fetuses with cystic hygroma diagnosed during the first 15 weeks of gestation.2003
- Increased nuchal translucency in fetuses with a normal karyotypePrenatal Diagnosis, 2002
- Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotypePrenatal Diagnosis, 2002
- DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathwaysHuman Molecular Genetics, 2000
- Down syndrome with partial duplication and del (21) syndrome: study protocol and call for collaboration. Study I: clinical assessmentClinical Genetics, 1996
- Confirmation of down syndrome critical region by FISH analysis in a patient with add(21)(p11)American Journal of Medical Genetics, 1995